ZFPM2-AS1 is reported to be involved in numerous tumors, including lung adenocarcinoma (78), renal cell cancer (79), gastric carcinoma (80) and HCC (81). This evidence concerns the gene ZFPM2 and renal cell adenocarcinoma.